Defeating Mooren Ulcer: Timely Diagnosis and Strategic Interventions for Swift Recovery
DOI:
https://doi.org/10.35749/oi.v52i1.101757Keywords:
Mooren Ulce, Steroid, Conjunctival Resection, Immunosuppressant , TherapyAbstract
Introduction: Mooren ulcer is a unique and rare manifestation of peripheral ulcerative keratitis of idiopathic origin, triggered by immunological abnormalities, genetic predispositions, and environmental factors. Case Report: We report the successful treatment of a rare case involving a 43-year-old man who presented with a significant worsening of white tissue covering cornea, severe pain, redness, and blurred vision in the left eye. An examination revealed a peripheral ulcer extending centrally with scleral sparing. Ancillary examinations yielded unremarkable findings. The patient was diagnosed with Mooren ulcer and initially treated with topical steroid, which showed no improvement. Therefore, a simultaneous conjunctival resection combined with immunosuppressive therapy was performed. At 1-year follow-up, no pain was reported, vision improved (6/21 to 6/12), and resolved ocular surface inflammation. Discussion: Mooren ulcer is often prone to misdiagnosis due to clinical signs that resemble other differential diagnoses. A meticulous examination is essential to carefully exclude autoimmune and corneal infection. The treatment goals are to arrest the destructive process and facilitate re-epithelization. A stepwise aggressive approach is crucial, starting with topical steroids to control inflammation. However, this single treatment modality may not prevent rapid progression, making conjunctival resection imperative to eliminate the source of collagenase production by cutting off the perilimbal blood vessels’ access to ulcer cites. Combining this with an immunosuppressant effectively maintains a stable condition. Conclusion: This case underscores the importance of timely diagnosis and aggressive treatment in preventing the swift progression of Mooren ulcer.
Downloads
References
Feder RS (editor). External Disease and Cornea: BCSC Basic and Clinical Science CourseTM. California: The American Academy of Ophthalmology 2023.
Srinivasan M, Zegans ME, Zelefsky JR, Kundu A, Lietman T, Whitcher JP, et al. Clinical characteristics of Mooren’s ulcer in South India. Br J Ophthalmol 2007;91(5):570–5.
Zhang Y, Fang X, Lin Z, Xie Z, Wu H, Ou S. Histopathology-based diagnosis of Mooren’s ulcer concealed beneath the pterygium on eye. J Histotechnol 2022;45(4):195–201.
Gupta Y, Kishore A, Kumari P, Balakrishnan N, Lomi N, Gupta N, et al. Peripheral ulcerative keratitis. Surv Ophthalmol 2021;66(6):977–98.
Alhassan MB, Rabiu M, Agbabiaka IO. Interventions for Mooren’s ulcer. Cochrane Database Syst Rev 2014;(1):CD006131.
Hassanpour K, ElSheikh RH, Arabi A, Frank CR, Elhusseiny AM, Eleiwa TK, et al. Peripheral Ulcerative Keratitis: A Review. J Ophthalmic Vis Res 2022;17(2):252-275.
Husain A, Saleem A, Zaidi ZA, Kazmi Z, Khawaja UA. Treating Mooren’s Ulcer - Squeezing Water From a Stone. Curēus 2020;12(12):e12248.
Çakmak Aİ, Akova Y, Yıldırım N. The Complete Success in Refractory Mooren’s Ulcer Treated with Infliximab. Ocul Immunol Inflamm 2023;31(4):682–8.
Li S, Deng Y, Du C, Huang H, Zhong J, Chen L, et al. Rapid deterioration of Mooren’s ulcers after conjunctival flap: a review of 2 cases. BMC Ophthalmol 2017;17(1):93.
Aaltonen V, Alavesa M, Pirilä L, Vesti E, Al-Juhaish M. Case report: bilateral Mooren ulcer in association with hepatitis C. BMC Ophthalmol 2017;17(1):239.
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2026 Florentina Priscilia, Dewa Ayu Anggi Paramitha, Yulia Aziza

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.